Literature DB >> 10391158

Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa.

E Edström1, S Gröndal, F Norström, M Palmér, K A Svensson, H Widell, B Hamberger.   

Abstract

OBJECTIVE: To evaluate the long-term results after subtotal adrenalectomy in patients with multiple endocrine neoplasia type IIa (MEN IIa).
DESIGN: Retrospective study.
SETTING: University Hospital, Sweden.
SUBJECTS: Five patients who underwent partial adrenalectomy between 1985 and 1989.
INTERVENTIONS: Subtotal adrenalectomy with a rim of cortical tissue left in situ. MAIN OUTCOME MEASURES: Follow up by interview, measurement of cortisol and catecholamine excretion in urine, and cortisol concentration in serum in response to stimulation with ACTH.
RESULTS: Three patients took no corticosteroids regularly, but during upper respiratory tract infections, or periods of severe stress they took 25 mg cortisone acetate daily. This is confirmed by their normal values of 24 hour urinary cortisol excretion and subnormal responses to an ACTH-stimulation test. The fourth and fifth patients had low concentrations of endogenous corticosteroids postoperatively, which is being replaced with 25 mg cortisone acetate daily. Postoperatively all five patients had low urinary adrenaline excretion.
CONCLUSION: Subtotal adrenalectomy in patients with MEN IIa resulted in basal endogenous corticosteroids within the reference range in three of five patients. There was no evidence of reduced adrenocortical function with time, nor were there any signs of recurrence of the pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391158     DOI: 10.1080/110241599750006659

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  7 in total

Review 1.  Partial adrenalectomy: underused first line therapy for small adrenal tumors.

Authors:  Deborah R Kaye; Benjamin B Storey; Karel Pacak; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-07       Impact factor: 7.450

Review 2.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

Review 3.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

4.  Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy.

Authors:  Michael Brauckhoff; Karsten Stock; Susanne Stock; Kerstin Lorenz; Carsten Sekulla; Katrin Brauckhoff; Phuong Nguyen Thanh; Oliver Gimm; Rolf Peter Spielmann; Henning Dralle
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

Review 5.  The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Authors:  Brian Shuch; Christopher J Ricketts; Adam R Metwalli; Karel Pacak; W Marston Linehan
Journal:  Urology       Date:  2014-03-15       Impact factor: 2.649

Review 6.  Partial adrenalectomy in patients with multiple adrenal tumors.

Authors:  C P Pavlovich; W M Linehan; M M Walther
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

7.  Is preservation of the adrenal vein mandatory in laparoscopic adrenal-sparing surgery?

Authors:  N Roukounakis; S Dimas; I Kafetzis; S Bethanis; N Gatsulis; H Kostas; V Kyriakou; S Michas
Journal:  JSLS       Date:  2007 Apr-Jun       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.